Imstem biotechnology inc
http://en.imstem.com.cn/ WitrynaImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of regenerative and cellular therapies. Pioneering research led to the proprietary state-of …
Imstem biotechnology inc
Did you know?
WitrynaAbout ImStem Biotechnology. Developer of commercial cell therapeutics to treat autoimmune diseases. The company's using human pluripotent cells to developing therapeutic products for tissue repair, and the treatment of neural, heart, vascular, blood system, and autoimmune diseases. Witryna10 cze 2013 · Contact Information Website www.imstem.com Ownership Status Privately Held (backing) Financing Status Formerly VC-backed Primary Industry Drug …
WitrynaImStem Biotechnology, Inc. Overview. ImStem Biotechnology, Inc is a private company. The company currently specializes in the Biotechnology area. The ImStem Biotechnology, Inc annual revenue is estimated at < 1M. To connect with ImStem Biotechnology, Inc employee register on SignalHire. Witryna29 mar 2024 · ImStem Biotechnology, Inc. (“ImStem”), a biopharmaceutical company developing human embryonic stem cell (ESC)-derived mesenchymal stem cells, dosed the first U.S. multiple sclerosis (MS) patient with ImStem’s lead investigational drug candidate IMS001 at the Shepherd Center in Atlanta, GA.
Witryna20 mar 2024 · And its development strategy focuses on neurologic, autoimmune, degenerative, and rare orphan diseases. ImStem Biotechnology, Inc. is a privately held company headquartered in Farmington, CT. For more information, visit http://www.imstem.com. FORWARD-LOOKING STATEMENTS Witrynaimstem 23 2024.08 Prof. Rudolf Jaenisch joins ImStem Biotechnology as Member of its Scientific Advisory Board Rudolf Jaenisch, a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research, joins ImStem Biotechnology as Member of Scientific Advisory Board. Learn More 19 2024.07
Witryna15 gru 2024 · Its development strategy focuses on neurologic, autoimmune, degenerative, and rare orphan diseases. ImStem Biotechnology Inc. is a privately held company headquartered in Farmington, CT. About IMS001 IMS001 is an investigational, allogeneic, MSC product derived from human embryonic stem cell line.
Witryna10 cze 2013 · Contact Information Website www.imstem.com Ownership Status Privately Held (backing) Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 400 Farmington Avenue R1808 Call Box 111 Farmington, CT 06032 United States +1 (860) 000-0000 Want … can my lebara line be monitoredWitrynaDr. Wang worked as a postdoctoral fellow at Yale School of Medicine and University of Connecticut’s Stem Cell Institute before he founded ImStem Biotechnology, Inc. … fixing meal for one peopleWitrynaImStem Biotechnology, Inc. As an innovative biopharmaceutical company incorporated in 2012, we are committed to translating our research findings in stem cell medicine … fixing medicaidWitrynaFind company research, competitor information, contact details & financial data for Imstem Biotechnology, Inc. of Newport Beach, CA. Get the latest business insights from Dun & Bradstreet. fixing mcdonalds ice cream machineWitrynaImStem was incorporated in 2012. As an innovative biopharmaceutical company, we aspire to improve patients' treatment outcomes and quality of life, targeting areas in … can my lawyer be my power of attorneyWitryna2 cze 2024 · ImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of … fixing maytag washer spindleWitrynaImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of regenerative and cellular therapies. Pioneering research led to the proprietary state-of-the-art pluripotent stem cell tec hnology, enabling off-the-shelf, allogeneic stem cell-derived products to be ... fixing medical equipment career